Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples